Cargando…
MALAT1 as master regulator of biomarkers predictive of pan-cancer multi-drug resistance in the context of recalcitrant NRAS signaling pathway identified using systems-oriented approach
NRAS, a protein mutated in several cancer types, is involved in key drug resistance mechanisms and is an intractable target. The development of drug resistance is one of the major impediments in targeted therapy. Currently, gene expression data is used as the most predictive molecular profile in pan...
Autores principales: | Kumar, Santosh, Mishra, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085754/ https://www.ncbi.nlm.nih.gov/pubmed/35534592 http://dx.doi.org/10.1038/s41598-022-11214-8 |
Ejemplares similares
-
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
por: Atefi, Mohammad, et al.
Publicado: (2015) -
Long non-coding RNAs as pan-cancer master gene regulators of associated protein-coding genes: a systems biology approach
por: Saleembhasha, Asanigari, et al.
Publicado: (2019) -
Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Cancer—An Integrated in Silico Approach
por: Alessandro, Larsen, et al.
Publicado: (2022) -
Mastering object-oriented Python
por: Lott, Steven F
Publicado: (2014) -
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
por: Kohtamäki, Laura, et al.
Publicado: (2021)